WysiWyg has established a drug safety management team to support contractors of domestic clinical trials.
It is well-know that the Trans-Pacific Partnership agreement has recently been reached. This global movement has caused changes in the trend of the Japanese pharmaceutical industry. Not only large-scale foreign pharmaceutical companies, but also small-scale companies marketing profitable drugs can now extend their business across the borders more easily than before. WysiWyg understands that such acts of pharmaceutical companies will influence company research organizations (CROs’) business.
To continue providing customers the best satisfaction in this new market trend, WysiWyg has established a new project team to actively provide supporting services for the drug safety management of small-scale pharmaceutical companies.
WysiWyg is ready to serve customers in English.
For a brief company profile (in English), please click below.
We are presently preparing a detailed company profile in English too.